Anthem Inc (ANTM)
US0367521038 - Common Stock
Overall ANTM gets a fundamental rating of 2 out of 10. We evaluated ANTM against 117 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of ANTM have multiple concerns. ANTM is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ANTM had positive earnings in the past year.
Each year in the past 5 years ANTM has been profitable.
Each year in the past 5 years ANTM had a positive operating cash flow.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.21% | ||
| ROE | 17.36% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ANTM does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 4.33% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ANTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ANTM has less shares outstanding
ANTM has a worse debt/assets ratio than last year.
2.2 Solvency
A Debt/Equity ratio of 0.55 indicates that ANTM is somewhat dependend on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC6.49%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
ANTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.56%, which is quite good.
Measured over the past years, ANTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.75% on average per year.
The Revenue has grown by 15.87% in the past year. This is quite good.
Measured over the past years, ANTM shows a quite strong growth in Revenue. The Revenue has been growing by 10.28% on average per year.
EPS 1Y (TTM)18.56%
EPS 3Y17.74%
EPS 5Y18.75%
EPS growth Q2Q17.69%
Revenue 1Y (TTM)15.87%
Revenue growth 3Y14.59%
Revenue growth 5Y10.28%
Revenue growth Q2Q17.63%
3.2 Future
Based on estimates for the next years, ANTM will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.81% on average per year.
Based on estimates for the next years, ANTM will show a small growth in Revenue. The Revenue will grow by 6.87% on average per year.
EPS Next Y12.48%
EPS Next 2Y12.93%
EPS Next 3Y13.13%
EPS Next 5Y12.81%
Revenue Next Year11.63%
Revenue Next 2Y8.34%
Revenue Next 3Y8.01%
Revenue Next 5Y6.87%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.74, the valuation of ANTM can be described as rather expensive.
When comparing the Price/Earnings ratio of ANTM to the average of the S&P500 Index (24.55), we can say ANTM is valued slightly cheaper.
ANTM is valuated correctly with a Price/Forward Earnings ratio of 14.57.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.92, ANTM is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.74 | ||
| Fwd PE | 14.57 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.45 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ANTM's earnings are expected to grow with 13.13% in the coming years.
PEG (NY)1.42
PEG (5Y)0.95
EPS Next 2Y12.93%
EPS Next 3Y13.13%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.09%, ANTM has a reasonable but not impressive dividend return.
With a Dividend Yield of 1.09, ANTM pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.09% |
5.2 History
On average, the dividend of ANTM grows each year by 14.64%, which is quite nice.
ANTM has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)14.64%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
ANTM pays out 18.19% of its income as dividend. This is a sustainable payout ratio.
The dividend of ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP18.19%
EPS Next 2Y12.93%
EPS Next 3Y13.13%
Anthem Inc
NYSE:ANTM (6/27/2022, 7:17:50 PM)
After market: 482.58 0 (0%)482.58
+12.71 (+2.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap116.34B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.09% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.74 | ||
| Fwd PE | 14.57 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.42
PEG (5Y)0.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.21% | ||
| ROE | 17.36% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 4.33% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)18.56%
EPS 3Y17.74%
EPS 5Y
EPS growth Q2Q
EPS Next Y12.48%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.87%
Revenue growth 3Y14.59%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y